Reports Q4 revenue $22.8M, consensus $44.64M. “We continue to progress our flagship rare disease programs and look forward to sharing ...

If you’ve been to the doctor and received treatment, that treatment was very likely built on NIH-supported research.

Without prescription drugs, Charlottesville resident Mara Shapiro and Norfolk resident Jillian Goodwin would be very ...

Approximately 1,000 new cases of Cystic Fibrosis are diagnosed each year that bring costly treatments to many families. The life-threatening genetic disorder is ...

About 99% of women with cystic fibrosis (CF) use contraception at least once during their fertile years, but unintended pregnancy is common.

The new chief medical officer of the Pulmonary Fibrosis Foundation speaks about patients in rural areas, research ...

A Dartmouth-led study reveals that infants with cystic fibrosis experience stalled gut microbiome development, potentially impacting long-term health. Researchers highlight the need for interventions ...

In a cohort of nearly 300 pediatric patients with cystic fibrosis, food allergy was found in less than 4% of the population, ...

Learn about idiopathic pulmonary fibrosis, its symptoms, diagnosis, and treatment options for managing this lung disease.

Vertex Pharmaceuticals (NASDAQ:VRTX) announced Friday that an expert panel of the EU drug regulator, the European Medicines ...

The American College of Chest Physicians (CHEST), the PF Warriors, the Rare Disease Diversity Coalition (RDDC)-a program at the Black Woman's Health Imperative-and the National Association of ...

The committee supports approving the CFTR modulator for patients 2 years and older with at least one non-class I CFTR gene mutation.